Article
[Investigation of Ganciclovir Resistance in Cytomegalovirus Strains Obtained from Immunocompromised Patients].
Mikrobiyoloji bulteni - 1 Oct 2020
Coşkun Ayşenur, Gökahmetoğlu Selma, Özmen Pelin, Çevik Şerife, Karakükçü Musa, Kaynar Leylagül, Midilli Kenan, Kuşkucu Mert Ahmet
Abstract excerpt
CMV is a virus that is asymptomatic in healthy individuals but can cause serious mortality and morbidity in transplant patients and patients with acquired immunodeficiency syndrome (AIDS). Ganciclovir (GCV) is a nucleoside analog that significantly reduces morbidity and mortality in CMV-related infections and is used as the first choice in treatment. It is the first drug shown to be effective in the treatment of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.